A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
- Resource Type
- Abstract
- Source
- In
Biology of Blood and Marrow Transplantation March 2020 26(3) Supplement:S190-S190 - Subject
- Language
- ISSN
- 1083-8791